Making Intelligent Connections Possible: Connected Devices – Better Devices

The process for identifying, selecting, and ultimately implementing connected devices in clinical trials can be overwhelming. The demand for connected devices in clinical trials has grown significantly, driven by a need for better, more expansive, more varied data, and more recently, by renewed bids to improve patient experience and reduce the burden for trial sites. The impact of the COVID-19 pandemic on on-site trials has been widely recognized; the net result has been a significant increase in demand for virtual technologies and telemedicine strategies that mitigate these challenges.

Complexity is best addressed through developing a deep understanding of the trial protocol, the study team’s requirements, and other considerations essential to the ultimate success of the trial. This drives a holistic view of both the vendor and the device, and into the technology itself, through activities like vendor assessments that encompass quality, security, data privacy, legal, and finance considerations. Equally important is to take a deeper dive into a potential device vendor, evaluating their core competencies, therapeutic experience, global reach, compliance, strategic direction, and other factors that could impact a trial.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.

About the author

Mike is the Director at IQVIA for Connected Devices in charge of strategic device partnerships and global logistics. Mike’s 20+ years of experience spans various industries. He is passionate about optimizing solutions and creating win-win partnerships to build the broadest, most innovative portfolio of medical grade devices for use in global clinical research, across all service lines, modalities and therapeutic areas.